Sponsor

On Target Laboratories, LLC

Clinical research sponsor

Published trials7
Recruiting shown1
Roles2
SourceClinicalTrials.gov

Clinical trials

7 shown
CYTALUX Dose Extension StudyNCT07469202 · lead sponsor · 2026-08-15
NOT_YET_RECRUITING
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor TargetingNCT04241315 · lead sponsor · 2020-03-26
COMPLETED
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung NodulesNCT02872701 · lead sponsor · 2017-05-04
COMPLETED
Safety and Feasibility of Intraoperative Visualization With Cytalux in ChildrenNCT06235125 · collaborator · 2024-04-08
RECRUITING
Safety and Efficacy of OTL78 (Zopocianine)NCT07725523 · collaborator · 2026-10-01
NOT_YET_RECRUITING
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 InjectionNCT06849544 · collaborator · 2025-04-02
COMPLETED
CYTALUX™for the Intraoperative Imaging of Prostate CancerNCT06434909 · collaborator · 2024-09-19
COMPLETED

Sponsor roles

collaborator4
lead sponsor3

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.